Search Results - "Tahamtan, Ouria"
-
1
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial
Published in JAMA : the journal of the American Medical Association (27-04-2021)“…IMPORTANCE: Thrombotic events are commonly reported in critically ill patients with COVID-19. Limited data exist to guide the intensity of antithrombotic…”
Get full text
Journal Article -
2
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial
Published in BMJ (Online) (07-01-2022)“…To assess the effect of statin treatment versus placebo on clinical outcomes in patients with covid-19 admitted to the intensive care unit (ICU)…”
Get more information
Journal Article -
3
Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study
Published in Thrombosis research (01-02-2021)“…Thrombosis and pulmonary embolism appear to be major causes of mortality in hospitalized coronavirus disease 2019 (COVID-19) patients. However, few studies…”
Get full text
Journal Article -
4
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
Published in Thrombosis and haemostasis (01-01-2022)“…Thrombotic complications are considered among the main extrapulmonary manifestations of coronavirus disease 2019 (COVID-19). The optimal type and duration of…”
Get more information
Journal Article -
5
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
Published in Thrombosis research (01-12-2020)“…Microvascular and macrovascular thrombotic events are among the hallmarks of coronavirus disease 2019 (COVID-19). Furthermore, the exuberant immune response is…”
Get full text
Journal Article -
6
Abstract 416: Atorvastatin Versus Placebo In Icu Patients With Covid19: Ninety-day Results Of The INSPIRATION-S Trial
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2023)“…Abstract only Backgrounds: In the INSPIRATION-S trial, atorvastatin versus placebo was associated with a non-significant 16% reduction in 30-day composite of…”
Get full text
Journal Article -
7
Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes
Published in European journal of internal medicine (01-09-2022)“…•Patients with COVID-19 admitted to ICU may have functional and mood impairment.•We showed improved functional status and mood over time in survivors of…”
Get full text
Journal Article